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ABSTRACT 
Objective. This population-based study compared cause-specific cancer survival by 
socioeconomic status using methods to more accurately assign cancer deaths to primary site.  
 
Methods. The current study analyzed Idaho data used in the Accuracy of Cancer Mortality 
Statistics Based on Death Certificates (ACM) study supplemented with additional 
information to measure cause-specific cancer survival by census tract poverty level.  
 
Results. The distribution of cases by primary site group differed significantly by poverty 
level (chi-square = 265.3, 100 df, p In the life table analyses, for 8 of 24 primary site groups 
investigated, and all sites combined, there was a significant gradient relating higher poverty 
with poorer survival. For all sites combined, the absolute difference in 5-year cause-specific 
survival rate was 13.6% between the lowest and highest poverty levels.  
 
Conclusions. This study shows striking disparities in cause-specific cancer survival related 
to the poverty level of the area a person resides in at the time of diagnosis. 
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INTRODUCTION 
Area variations in cancer outcomes, including survival, may be due to differences in 
public education and culture, extent of disease at diagnosis and access to optimal treatment. 
Many recent studies have shown social inequities in population health measures of cancer 
burden, including incidence (Clegg et al., 2009; McCarthy, Dumanovsky, Visvanathan, Kahn, & 
Schymura, 2010; Singh, Miller, Hankey, & Edwards, 2003; Singh, Miller, Hankey, & Edwards, 
2004), mortality (Singh et al., 2003; Singh et al., 2004; Ward et al., 2004), stage distribution 
(Clegg et al., 2009; Colorado Cancer Coalition, 2002; Hahn et al., 2007; McCarthy et al., 2010; 
Singh et al., 2003; Singh et al., 2004), and survival (Artinyan et al., 2010; Bradley, Given, & 
Roberts, 2004; Byers et al., 2008; Colorado Cancer Coalition, 2002; Dalton et al., 2007; Du, 
Fang, & Meyer, 2008; McCarthy et al., 2010; Meliker, Goovaerts, Jacquez, Avruskin, & 
Copeland, 2009; Movva et al., 2008; Niu, Pawlish, & Roche, 2010; Schwartz et al., 2009; Simon 
et al., 2006; Singh et al., 2003; Singh et al., 2004; Yan et al., 2009; Zell et al., 2008). 
Recognizing the impact of social inequality on health, Healthy People 2020 and the Idaho 
Comprehensive Cancer Strategic Plan include goals to measure and eliminate health disparities 
(Comprehensive Cancer Alliance for Idaho, 2006; U.S. Department of Health and Human 
Services [USDHHS], 2011a). Unfortunately, socioeconomic data are largely absent from most 
U.S. public health surveillance systems. Population-based cancer registries collect information 
on demographic variables including age, sex, race and ethnicity, but do not routinely collect 
information on patient income or education, for example. An efficient solution to the problem of 
absent socioeconomic data in population-based cancer registries is to geocode residential 
addresses and use area-based socioeconomic measures (ABSMs) (Krieger, Chen, Waterman, 
Rehkopf, & Subramanian, 2003; Krieger et al., 2002; Krieger, Waterman, Chen, Rehkopf, & 
Subramanian, 2004). 
The current study analyzed Idaho data used in the Accuracy of Cancer Mortality 
Statistics Based on Death Certificates (ACM) study (Fink et al., 2011; German et al., 2011), 
supplemented with address information of cases at the time of diagnosis to measure cause-
specific cancer survival by census tract poverty level. The main objective of the ACM study was 
to estimate the agreement of primary cancer site between the central cancer registry and death 
certificate data sources. The methods have been described in detail previously (German et al., 
2011). As part of the ACM study, cancer cases and deaths were carefully categorized and 
matched, resulting in a high quality dataset for accurate causespecific survival analyses. 
There are two common measures of net survival from cancer: causespecific survival and 
relative survival (Brown, 1983; Ederer, Axtell, & Cutler, 1961; Marubini & Valsecchi, 1995). 
Cause-specific survival requires that choices be made regarding assigning attributable deaths, 
and both methods may require decisions about excluding some cases (e.g. second or later 
primary cases) from analysis. Relative survival methods are often used when information on 
cause of death is unreliable, but require appropriate life tables to calculated expected survival 
rates (Ederer et al., 1961). Competing causes of death are not distributed equally among 
socioeconomic classes (in essence, different socioeconomic classes have different life tables). 
Life tables are generally not available by socioeconomic position, and using expected survival 
from inappropriate life tables may result in biased estimates of survival from cancer.  
We used data from a high quality population-based registry that utilized enhanced 
methods for matching UCD to primary site group in order to test the hypothesis that cause-
specific cancer survival would vary by census tract poverty level. Compared to other 
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comprehensive population-based studies of cancer survival and socioeconomic status (SES) in 
the U.S. (Byers et al., 2008; Colorado Cancer Coalition, 2002; Niu et al., 2010; Singh et al., 
2003; Ward et al., 2004), this study included more cancer sites, had a longer follow-up period, 
used results of the ACM study to more accurately assign cancer deaths to primary site, and 
utilized finer poverty level categories. We included all primaries for individuals with more than 
one primary cancer (Brenner & Hakulinen, 2007; Ellison, 2010; Rosso et al., 2009) and assigned 
the cause-specific cancer cause of death to the appropriate primary. 
 
METHODS 
In the ACM study, data from central cancer registry records from California, Colorado, 
and Idaho were linked with death certificates from the corresponding state vital statistics 
registries and evaluated by demographic and tumor information (Fink et al., 2011; German et al., 
2011). Long-term prospective and retrospective concordances of primary site category were 
measured using ICD-O- 3 codes from the cancer registry and ICD-9 and ICD-10 codes for the 
underlying cause of death (UCD) from the death certificate (Fritz et al, 2000; World Health 
Organization [WHO], 1978; WHO, 2007) These states were selected to participate based on 
several criteria that ensured high-quality death clearance data, including the ability to perform 
valid linkages between the cancer registry and mortality data. Idaho resident primary invasive 
cancer casesa diagnosed in 1993 through1995 were followed up to 2004 via a combination of 
ongoing activeatient follow-up, complete manual review of Idaho death certificates for the 
period 1993 through2000, and linkages with both Idaho death certificates and the National Death 
Index (NDI) (USDHHS, 2000) covering deaths in 1993 through 2004. We conducted cause-
specific survival analyses by poverty level of the census tract in which the case resided at the 
time of diagnosis. 
Cancer Incidence Data 
Incidence data on Idaho residents with primary invasive cancer cases diagnosed in 1993 
through1995 were obtained from the Cancer Data Registry of Idaho (CDRI), the central cancer 
registry for the state of Idaho. CDRI has functioned since 1969 and has been population-based 
since 1971. CDRI has achieved North American Association of Central Cancer Registries 
(NAACCR) and/or U.S. Centers for Disease Control and Prevention (CDC) National Program of 
Cancer Registries (NPCR) standards for data completeness, timeliness and quality since 1993 
(North American Association of Central Cancer Registries, 2011; USDHHS, 2011c). Audits 
evaluating data quality and completeness performed by NAACCR in 1996 and by CDC in 2000 
and 2007 have shown completeness rates of 98%- 99.6% and error rates lower than the median 
error rates for central cancer registries (USDHHS, 2011d). 
Follow-up Information 
CDRI is one of few central cancer registries not part of the National Cancer Institute’s 
Surveillance, Epidemiology, and End Results (SEER) program to have performed active patient 
follow-up to ascertain vital status. For patients included in this study, annual follow-up was 
performed through mailings to the patients’ physicians. Official date and cause of death 
information was obtained via linkages with state vital statistics and the NDI (USDHHS, 1999; 
USDHHS, 2000). 
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State Death Certificates 
Probabilistic linkages were conducted between the CDRI database encompassing cases 
from1993 through1995 and death certificate data encompassing deaths in 1993 through 2004 in 
Idaho using Link Plus software (V2.0, CDC, Atlanta, Georgia). Link Plus computes probabilistic 
record linkage scores based on the theoretical framework developed by Fellegi and Sunter 
(1969). Social Security number, birth date, Soundex of last name, Soundex of first name, and 
Federal Information Processing Standards (FIPS) county code were used as blocking variables 
and last name, first name, middle name, Social Security number, birth date, FIPS county code, 
and sex were used as matching variables. Visual review of the linkage results file was used to 
determine high and low cutpoints for match scores. Records with scores above the high cutpoint 
were deemed to be true matches. Records with scores below the low cutpoint were deemed to be 
false matches. Records with intermediate scores were reviewed manually using additional 
resources including the Social Security Death Index, the full cancer registry record, and the full 
death certificate.  
In addition, during the period 1993 through 2000, Idaho conducted complete manual 
review of Idaho death certificates for the death clearance process (Johnson, Carson, & Wick, 
2004). This process resulted in 55 additional matches between CDRI cases and Idaho death 
certificates listing cancer as the UCD. 
National Death Index 
In order to obtain date and cause of death information on persons who were diagnosed 
with cancer as an Idaho resident during 1993 through1995 and who may have died in another 
state during the period of 1993 through 2004, records that did not link to an Idaho death 
certificate were submitted to the National Center for Health Statistics (NCHS) for an NDI search 
(USDHHS, 2000). The NDI is a national file of identifying death record information compiled 
from data submitted by State vital statistics offices. NCHS conducts NDI searches and provides 
the NDI user with an indication that an individual in the user’s file has been involved in a 
possible match with one or more records in the NDI file. CDRI used an algorithm developed by 
NPCR registries for use in the CONCORD study to determine which potential NDI matches 
were indeed true matches (Coleman et al., 2008; Johnson, McLaughlin, Copeland, Weir, & 
NPCRCONCORD Workgroup, 2002); 
Underlying Cause of Death 
For deaths in Idaho, UCD was obtained from Automated Classification of Medical 
Entities codes from the NCHS enhanced Mortality Medical Indexing, Classification, and 
Retrieval system (SuperMICAR) files (USDHHS, 2011b). For deaths in other states, the NDI 
Plus service was used to obtain cause of death information (USDHHS, 1999). 
Categorization of Primary Site and Assignment of Cause of Death 
We categorized cancer incidence and mortality data using the 25 cancer site groups that 
are used in the “United States Cancer Statistics” publication (USDHHS, 2010) and the ACM 
study (German et al., 2011). Incidence data were categorized using primary site, histology, and 
behavior codes converted from ICD-O-2 to ICD-O-3. Deaths were categorized using UCD codes 
(ICD-9 for deaths in 1993 through1998, ICD-10 for deaths in 1999 through 2004). The 
Kaposi’s sarcoma group is not included in the site-specific results because fewer than 10 cases 
were available for this analysis. 
We attributed cause-specific deaths to individual primary sites for persons in this study. 
For patients with only one primary cancer listed in the cancer registry data, any cancer UCD was 
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considered to have arisen from the primary site, including cancer deaths potentially misattributed 
to metastatic sites. For persons with more than one primary cancer listed in the cancer registry 
data, the cancer death was attributed to the primary that matched the analysis group of the UCD. 
For persons with more than one primary cancer, and for whom the cancer cause of death analysis 
group did not agree with any of the primary sites, the linked incidence/mortality records were 
reviewed by two Certified Tumor Registrars to assign the UCD to the appropriate primary 
cancer. If the death grouping was for a site listed as a metastatic site for a particular primary, this 
was deemed to be a match. For 26 cases it was not possible to match the primary site to the 
cancer death grouping because the cancer death code was for “multiple primary” cancers, the 
death certificate text included mention of more than one specific cancer site, and the person had 
each of the specific cancer primaries. These cases were excluded from all analyses. However, if 
the person had additional primaries not coded or mentioned in the death certificate, these cases 
were included in the analysis and censored at date of death. In a few instances, the cancer death 
code was different from all of the primaries, and could not have been a metastatic site (e.g., 
potential missed case or not reportable because the cancer occurred while the person resided in 
another state and no treatment was provided by Idaho hospitals). These cases were included in 
the analysis and censored at date of death. For persons with more than one cancer of the same 
primary site and whose cancer death matched the analysis group (41 persons: 19 with colon and 
rectum cancer, 12 with breast cancer, 7 with lung and bronchus cancer, 1 each of kidney and 
renal pelvis, non-Hodgkin lymphoma, and oral cavity and pharynx), the cancer death was 
attributed to each primary. This decision was made because the subsites and/or histology codes 
varied for each case within a person, the fact of which was masked by categorization into 
analysis group. We grouped individuals with single and multiple primaries in the same analyses, 
consistent with recent trends in cancer survival methods (Brenner & Hakulinen, 2007; Ellison, 
2010; Rosso et al., 2009). Non-cancer deaths were censored at date of death in the statistical 
analysis.  
Geocoding of Cases and Assignment of 1990 Census Tract Poverty Level 
We geocoded cancer incidence records to 1990 census tract based on address of residence 
at the time of diagnosis (Krieger et al., 2002). A census tract is a subdivision of a county that 
contains on average about 4,000 persons and boundaries are drawn such that the population 
covered is relatively homogenous. The percentage of the population with incomes below federal 
poverty guidelines was calculated by 1990 census tract, and tracts were categorized by poverty 
status into four groups: 0.0-4.9%, 5.0-9.9%, 10.0-19.9%, and 20.0+ (Krieger et al., 2002; Krieger 
et al., 2003; Krieger et al., 2004). This measure of socioeconomic inequality was selected based 
on recommendations by the Public Health Disparities Geocoding Project regarding validity, 
robustness, and completeness criteria (Krieger et al., 2002). 
Statistical Analysis 
We calculated cause-specific cancer survival rates by the four census tract poverty levels 
and overall using the actuarial (life table) method in SEERStat (Berkson & Gage, 1950; 
USDHHS, 2011e). The study cutoff date was set to December 2004. If the last follow-up date for 
a person was after the study cutoff, the end date for the person was set to the study cutoff and 
vital status was set to alive. We excluded cases from analysis if they were reported by autopsy or 
death certificate only (231 cases), had unknown or missing cause of death (251 cases), had vital 
status alive but no follow-up time (72 cases), or died due to other causes and had no follow-up 
time (80 cases). Cases were censored at either the date of death, last follow-up, or study cutoff 
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and using the rules regarding primary site and death analysis group matches detailed above. We 
computed the Wilcoxon test for trend and p-values comparing survival functions from the four 
census tract poverty levels using SAS Proc Lifetest (Version 9.2, Cary, NC: SAS Institute, Inc.). 
The test for trend compared the null hypothesis that the four population hazard rates were the 
same versus an ordered alternative: S0.0-4.9%(t) ≥ S5.0-9.9%(t) ≥ S10.0-19.9%(t) ≥ S20.0+(t), with at least 
one inequality. Trend tests have more power to detect ordered alternatives such as that specified 
(Klein & Moeschberger, 1997).  
We ran Cox proportional hazards models overall and by cancer site to estimate the hazard 
ratios associated with census tract poverty level as compared to the low poverty group (0.0-4.9% 
poverty). The Cox models were run in SAS (V9.2) Proc PHREG and adjusted for age at 
diagnosis, sex, and sequence of cancer (first primary versus subsequent primary). Age at 
diagnosis and the square of age at diagnosis were included in the models to account for non-
linear relationships between age and survival time. Race was not adjusted for in the Cox models 
because 96.9% of cases were among non-Hispanic whites and the other race and ethnicity data 
were too sparse. The greatest number of cases for other than whites was 47 cases of breast cancer 
among Hispanics (2.5% of cases). Most site by race (or ethnicity) counts were less than 10 cases 
at entry. Ties in failure time were handled using the approximate likelihood of Efron (1977). 
Cases were censored using the same rules as for the life tables. 
Human Subjects Protections 
The ACM study received a non-research determination from the CDC. Use of non-
identifying data in this study was approved by the Cancer Data Registry of Idaho. To ensure the 
protection of patient confidentiality, table cells based on five or fewer cases are suppressed in the 
results. 
 
RESULTS 
A total of 12,851 Idaho resident cancer cases diagnosed from 1993 through1995 was 
included in the statistical analysis, 10,943 of which were the first primary. For 82 cases, census 
tract was unable to be assigned due to unknown address information besides state of residence; 
these were excluded from analysis by poverty status. For the survival data censored as of 
December 2004, cause of death was determined from state death certificates for 7,733 cases and 
from NDI for 476 cases. 
Table 1 shows counts and percentages of incident cases from 1993, 1994, and 1995 that 
entered into the survival analyses by primary site group and 1990 census tract poverty level. The 
distribution of cases by primary site group differed significantly by poverty level (chi-square = 
265.3, 100 df, p<0.0001). There were higher percentages of breast and melanoma of the skin 
cases, and lower percentages of colon and rectum and lung and bronchus cases in the lowest 
(0.0-4.9%) poverty level census tracts. For tobacco-related cancers (e.g. esophagus, larynx, lung 
and bronchus), incidence patterns were consistent with higher smoking rates in areas with higher 
census tract poverty. 
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Overall cause-specific cancer survival among Idaho residents diagnosed with primary 
invasive cancers from 1993 through1995 was 61.2% at 5 years and 54.5% at 10 years. Tables 2 
and 3 show 5-year and 10-year cause-specific cancer survival by primary site group and 1990 
census tract poverty level. Cause-specific survival at 5 years varied by primary site group from 
6.1% for pancreas to 95.0% for thyroid. At 10 years, cause-specific survival varied from 4.9% 
for pancreas to 92.9% for testis. 
For eight primary site groups (breast, esophagus, larynx, leukemia, melanoma of the skin, 
oral cavity and pharynx, prostate, and urinary bladder) and all sites combined, there were 
significant differences (p<0.05) among poverty levels in cause-specific cancer survival evaluated 
at either 60 or 120 months. For each primary site group besides breast and larynx, there were 
monotonic decreases in cause-specific cancer survival with increasing poverty level. For breast 
cancer, the differences in 60 and 120 month survival between the 0.0-4.9% and 5.0-9.9% poverty 
levels were not statistically significant, and there were lower survival rates for the remaining 
higher poverty levels. Data by poverty level were sparse for the larynx group, but the lower two 
poverty levels had higher survival rates than the higher two poverty levels. For melanoma of the 
skin and oral cavity and pharynx cancers, the highest poverty level had distinctly poorer survival 
than the remaining poverty levels. In all of these primary site groups except leukemia, the 
absolute differences in survival by poverty level increased from the time of diagnosis to 5-years 
post-diagnosis (data not shown). The differences by poverty level continued to increase from 5 to 
10 years for breast and prostate cancers. 
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For all sites combined, the absolute difference in 5-year cause-specific survival rate was 
13.6% between the lowest and highest poverty levels. By primary site group, the survival 
disparity was 4.5% for breast cancer, 12.5% for esophagus, 29.0% for larynx, 29.3% for 
leukemia, 20.0% for melanoma of the skin, 31.6% for oral cavity and pharynx, 11.6% for 
prostate, and 15.8% for urinary bladder. 
Table 4 shows 5-year and 10-year cause-specific cancer survival by sex and 1990 census 
tract poverty level for all sites combined and for each primary site group with ≥ 500 cases (colon 
and rectum, lung and bronchus, melanoma of the skin, non-Hodgkin lymphoma, and urinary 
bladder; breast and prostate previously shown). For all sites combined, there were significant 
differences (p<0.05) among poverty levels in cause-specific cancer survival evaluated at 60 and 
120 months for both males and females. None of the individual primary site groups had a 
significant difference (p<0.05) among poverty levels in cause-specific cancer survival. Among 
males, the difference in cause-specific cancer survival by poverty level approached statistical 
significance (p<0.10). For all sites combined, the survival disparity was about twice as high for 
males as for females, owing mostly to the survival disparity in lung cancer survival. 
 
 
 
Table 5 shows results of the Cox models, adjusting for age at diagnosis, sex, and 
sequence of cancer. For two primary site groups (female breast and prostate) and all sites 
combined, there were significant differences among poverty levels in cause-specific cancer 
survival (p<0.05). For an additional three sites (esophagus, leukemias, and oral cavity and 
pharynx), there were differences among poverty levels in cause-specific cancer survival that 
approached statistical significance (p<0.10). For each of these primary site groups besides breast 
and leukemias, there were monotonic increases in the hazard ratios compared to the 0.0-4.9% 
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poverty level with increasing poverty level. For breast cancer, the hazards were similar in the 
0.0-4.9% and 5.0-9.9% poverty levels, but there were increased hazards for the remaining higher 
poverty levels. For leukemias, the poverty level 5.0-9.9% showed essentially the same hazard as 
the 0.0-4.9% poverty level, but increased hazards for the remaining higher poverty levels. 
 
 
 
DISCUSSION 
This study shows striking disparities by poverty level of the area a person resides in at the 
time of diagnosis in cause-specific cancer survival. In the life table analyses, for 8 of 24 primary 
site groups investigated, and all sites combined, there was a significant gradient relating higher 
poverty with poorer survival. 
These results are comparable in direction and magnitude to several other studies that 
investigated socioeconomic disparities in cancer survival. Using cases diagnosed during 1988 
through1994, the SEER program analyzed areabased socioeconomic variation in cancer survival 
for all sites combined and for six major cancers (lung, colorectal, prostate, breast, cervix, and 
melanoma of the skin) (Singh et al., 2003; Singh et al., 2004; Ward et al., 2004). SEER used 
cutpoints of <10%, 10-19.9%, and 20%+ poverty measured at the census tract level of 
geography. Persons in high poverty census tracts generally had lower rates of cancer survival 
than those in low poverty census tracts for all cancers combined and the individual cancers 
considered. For all sites combined, there was a 12.0% absolute difference in 5-year cause-
specific survival for males, and 10.3% for females (Singh et al., 2003). This difference was 
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greater for all sites combined than for individual sites due to differences in site distribution 
among the SES categories. For individual sites, the absolute differences in 5-year causespecific 
survival were 4.6% for male lung, 4.4% for female lung, 7.8% for male colorectal, 6.2% for 
female colorectal, 6.9% for prostate, 8.9% for female breast, 6.5% for cervix, 11.4% for 
melanoma male, and 7.6% for melanoma female. Not only did the highest poverty areas have 
lower survival, but there was also a poverty-related survival gradient which generally held across 
race and ethnicity categories. 
The Colorado Cancer Coalition (2002) employed methods similar to those used in the 
NCI report; they used the same three poverty categories (<10, 10-19, 20+), but assigned poverty 
based on census block group or ZIP Code instead of census tract. Colorado found lower 5-year 
cause-specific survival in poorer areas for all sites combined and specific sites. The absolute 
survival deficit for the highest poverty areas compared to the wealthiest areas was 14.4% for all 
sites combined, 6.5% for breast cancer, 11.9% for colorectal, 13.8% for melanoma, and 7.9% for 
prostate cancer. 
Results of the Cox models are consistent with previous reports of increased hazard of 
death associated with lower SES for several cancer sites. In a study conducted using Detroit 
metropolitan area SEER data, the hazard of breast cancer-specific death was higher among 
persons residing in census blocks categorized as working poor versus professional (HR=1.32 for 
localized disease, 1.16 for regional disease), adjusting for race, age, tumor characteristics, and 
treatment (Simon et al., 2006). The hazard of dying from early stage breast cancer among women 
aged 65+ in the SEER-Medicare linked database diagnosed in 1992 through1999 and followed 
for up to 11 years was 7% higher in the highest census tract poverty quartile versus the lowest in 
a model adjusting for age, marriage status, tumor stage, size, grade, hormone receptor status, 
comorbidity, year of diagnosis, SEER region, primary surgery and radiotherapy, and 
chemotherapy (Du et al., 2008). Among women aged younger than 65 years in Michigan 
diagnosed with cervical cancer in 1996 through1997 and followed up to 1998, the HR of death 
from cervical cancer for Medicaid-enrolled at diagnosis versus non-Medicaid-insured was 1.77, 
and the HR for Medicaid-enrolled after diagnosis was 2.40, adjusting for age, race, and stage 
(Bradley et al., 2004). Melanoma-specific survival was higher among persons residing in census 
blocks in the highest quintile of SES compared to the lowest (HR=0.68) in a California study that 
also adjusted for age, sex, race/ethnicity, stage, histologic subtype, anatomic subsite, and therapy 
(Zell et al., 2008). These results suggest widespread disparities in cause-specific cancer survival 
by SES, with variations in magnitude by primary site and presence of stage and treatment 
variables in multivariate models. 
Many of the differences in survival among persons living in high and low poverty areas 
are likely to stem largely from disparities in access to screening (stage shift) and high-quality 
cancer treatment. The Colorado study found the largest poverty gradient for survival for regional 
stage cases, which may suggest differences in treatment patterns by poverty level. Treatment 
delay has been shown to be caused by insufficient clinical investigations by health care providers 
and a lack of awareness of the potential meaning of symptoms (Pagano et al., 2003). The SEER 
study found that stage at diagnosis did not fully account for the socioeconomic differences in 
survival (Singh et al., 2003; Singh et al., 2004; Ward et al., 2004). In a study of a nationwide 
cohort of breast cancer cases in Denmark, poorer management of comorbid conditions was 
suggested as a partial explanation of the social inequality in survival (Dalton et al., 2007). In the 
U.S., lack of health insurance is a critical barrier to receiving recommended preventive care, 
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cancer screening and treatment (USDHHS, 2006; USDHHS, 2007; Ward et al., 2008). While the 
U.S. Department of Health and Human Services has an objective to address cancer health 
disparities through the unbiased access to continuous quality preventive care, early detection, and 
treatment, evidence in fact suggests that the SES gap is widening in the U.S. and elsewhere 
(Coleman et al., 2004; Singh et al., 2004; USDHHS, 2004). It was not our intention in this study 
to differentiate decrements in survival as arising from late screening/stage versus inferior 
treatment. 
The interpretation of differences in cause-specific cancer survival among poverty levels 
is made more complicated for cancers amenable to screening due to potential lead-time bias. 
Differences in screening prevalence among different poverty levels is a function of health care 
access, and may result in cancer diagnosis at earlier stages and at earlier ages among populations 
with higher screening rates. However, better survival among higher SES groups may reflect 
earlier diagnosis, not postponement of the date of death. Lead-time bias may occur within a 
stage, not just between stages, so adjustment for stage in statistical models may not fully account 
for it (Berrino, Estève, & Coleman, 1995). For prostate cases, in particular, lead-time bias may 
extend to a long detectable preclinical phase or indolent tumors. 
Many studies of the impact of SES on stage distribution and cancer survival sought to 
disentangle the effects of race/ethnicity from those of SES. Differences in cancer survival by 
race have been associated with insurance status, screening prevalence, and SES (Du et al, 2008; 
Hahn et al., 2007; Movva et al., 2008; Ward et al., 2004). Some studies found persistent 
differences by race/ethnicity after adjusting for SES (McCarthy et al., 2010; Niu et al., 2010; 
Simon et al., 2006; Zell et al., 2008), others found no significant effects for measures of SES 
after adjusting for race (Artinyan et al., 2010; Dash et al., 2008), and others found no significant 
race effects after adjusting for SES (Meliker et al., 2009; Schwartz et al., 2009; Yan et al., 2009). 
The race distribution in Idaho (94.4% white race in 1990 Census) precluded us from 
investigating the independent effect of race in this study, yet our results are also unlikely to be 
confounded by race (U.S. Census Bureau, n.d.). 
As cancer survival improves over time, increasing numbers of individuals are diagnosed 
with multiple primary cancers. The CDRI has been populationbased since 1971, so long-term 
survivors of cancers diagnosed in the 1970s and 1980s were more able to have been assigned the 
proper match between cancer death and primary site, reducing a potential source of bias among 
persons with multiple primaries spanning many years or decades. 
Limitations 
The relatively low numbers of cancer cases in Idaho mean that there may not have been 
sufficient power to detect significant differences in cause-specific cancer survival by poverty 
level for some primary site groups or by sex. Also, the differences in survival may be related to 
differences in sub-site or histologic type distribution, but could not be analyzed separately due to 
sparse data (Berrino et al., 1995). 
The cases used in this analysis were diagnosed with first or later primary cancers during 
1993 through1995 and followed up to the end of 2004. The survival rates presented may be 
lower than experienced by patients diagnosed in more recent years due to improvements in 
treatment and changes in risk factor and/or screening prevalence for some cancer sites (e.g. 
Idaho’s Early Detection Program for Breast and Cervical Cancers has increased screening among 
low income women in certain age groups) (Idaho Department of Health and Welfare, 2011). 
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A potential criticism of this study is that poverty was measured at the census tract at the 
time of diagnosis, not the individual level. Data on socioeconomic measures such as education 
and income are not routinely available in cancer registry records. Nonetheless, Krieger and 
colleagues have demonstrated that well chosen area-based socioeconomic measures can be used 
to examine socioeconomic inequalities in health (Subramanian, Chen, Rehkopf, Waterman, & 
Krieger, 2006a; Rehkopf et al., 2006). Area-based socioeconomic measures need not be thought 
of as proxies for (unavailable) individual measures, but instead capture components of individual 
and area-based health influences (Subramanian, Chen, Rehkopf, Waterman, & Krieger, 2006b). 
The potential risk of using area-based socioeconomic measures when measures on individuals 
are lacking is to underestimate socioeconomic disparities. 
Conclusion 
The purpose of this study was to describe cause-specific cancer survival by census tract 
poverty level using population-based data with high quality death coding. We found significant 
or suggestive differences in cause-specific survival by poverty level for several individual cancer 
sites and all sites combined. The results of our study underscore the need for the health 
disparities objectives promoted by Healthy People 2020 and the Idaho Comprehensive Cancer 
Strategic Plan (Comprehensive Cancer Alliance for Idaho, 2006; USDHHS, 2011a). We are 
hopeful that the results of this and other studies can guide programs to achieve these objectives 
by focusing attention on cancer sites with significant poverty-related survival disparities. 
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